SEROQUEL XR Trademark

Trademark Overview

On Thursday, March 23, 2006, a trademark application was filed for SEROQUEL XR with the United States Patent and Trademark Office. The USPTO has given the SEROQUEL XR trademark a serial number of 78844481. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, March 7, 2018. This trademark is owned by AstraZeneca UK Limited. The SEROQUEL XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system
seroquel xr

General Information

Serial Number78844481
Word MarkSEROQUEL XR
Filing DateThursday, March 23, 2006
Status800 - REGISTERED AND RENEWED
Status DateWednesday, March 7, 2018
Registration Number3401829
Registration DateTuesday, March 25, 2008
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2006
Primary Code005
First Use Anywhere DateMonday, August 6, 2007
First Use In Commerce DateMonday, August 6, 2007

Trademark Owner History

Party NameCHEPLAPHARM ARZNEIMITTEL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressGREIFSWALD 17489
DE
Party NameAstraZeneca UK Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSödertälje SE-15185
SE
Party NameAstraZeneca UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLondon W1K 1LN
GB
Party NameAstraZeneca UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLondon W1K 1LN
GB

Trademark Events

Event DateEvent Description
Thursday, September 7, 2006ASSIGNED TO EXAMINER
Wednesday, September 13, 2006NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2006NON-FINAL ACTION E-MAILED
Friday, October 27, 2006PAPER RECEIVED
Wednesday, March 29, 2006NEW APPLICATION ENTERED
Saturday, June 2, 2007SUSPENSION INQUIRY WRITTEN
Saturday, June 2, 2007INQUIRY TO SUSPENSION E-MAILED
Tuesday, July 31, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 31, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 26, 2007TEAS AMENDMENT OF USE RECEIVED
Tuesday, November 27, 2007USE AMENDMENT FILED
Monday, November 27, 2006ASSIGNED TO LIE
Monday, November 27, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 27, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, November 27, 2006SUSPENSION LETTER WRITTEN
Monday, November 27, 2006LETTER OF SUSPENSION E-MAILED
Friday, June 1, 2007SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, November 27, 2007AMENDMENT TO USE PROCESSING COMPLETE
Thursday, November 29, 2007EXAMINERS AMENDMENT -WRITTEN
Thursday, November 29, 2007USE AMENDMENT ACCEPTED
Thursday, November 29, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2007EXAMINER'S AMENDMENT ENTERED
Monday, December 3, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 25, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, February 26, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, March 18, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 18, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, March 25, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 19, 2007NOTICE OF PUBLICATION
Tuesday, January 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 18, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 7, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2018TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 7, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 7, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 7, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, August 12, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 12, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, August 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

seroquel central nervous system disorders diseases preparations substances treatment pharmaceutical